HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices

Heart Rhythm

Volumn 12, Issue 7, 2015, Pages e69-e100

  Slotwiner, David ^a   Varma, Niraj ^b   Akar, Joseph G ^c   Annas, George ^d   Beardsall, Marianne ^e   Fogel, Richard I ^f   Galizio, Nestor O ^g   Glotzer, Taya V ^h   Leahy, Robin A ⁱ   Love, Charles J ^j   McLean, Rhondalyn C ^k   Mittal, Suneet ^l   Morichelli, Loredana ^m   Patton, Kristen K ⁿ   Raitt, Merritt H ^o   Pietro Ricci, Renato ^m   Rickard, John ^p   Schoenfeld, Mark H ^c   Serwer, Gerald A ^q   Shea, Julie ^r   Varosy, Paul ^s   Verma, Atul ^e   Yu, Cheuk Man ^t   more..

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^f St Vincent Medical Group   (United States)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^h HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ LEVINE CANCER INSTITUTE   (United States)

^j NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l Arrhythmia Institute at Valley Hospital   (United States)

^m SAN FILIPPO NERI HOSPITAL   (Italy)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^p JOHNS HOPKINS UNIVERSITY   (United States)

^q UNIVERSITY OF MICHIGAN   (United States)

^r BRIGHAM AND WOMEN S HOSPITAL   (United States)

^s UNIVERSITY OF COLORADO   (United States)

^t CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Cardiac resynchronization therapy; Cardiac resynchronization therapy defibrillator; Implantable cardioverter defibrillator; Pacemaker; Remote monitoring

Indexed keywords

ARTICLE; ATRIAL FIBRILLATION; CARDIAC PATIENT; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CERTIFICATION; CHANNELOPATHY; CONSENSUS; DEVICE LONGEVITY; DISEASE SURVEILLANCE; ELECTRICAL EQUIPMENT; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART FAILURE; HISTORY OF MEDICINE; HOME MONITORING; HUMAN; IMPLANTABLE CARDIAC MONITOR; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; MEDICAL STAFF; MEDICAL TECHNOLOGY; NURSE PRACTITIONER; PATIENT MONITORING; PATIENT SAFETY; PATIENT SATISFACTION; PHYSICIAN; PHYSICIAN ASSISTANT; PRIORITY JOURNAL; PRIVACY; PRODUCT PARAMETERS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; REMOTE INTERROGATION; REMOTE SENSING; RESPONSIBILITY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLASSIFICATION; DEVICES; DISEASE MANAGEMENT; HEART DISEASES; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERNATIONAL COOPERATION; PROCEDURES; PSYCHOLOGY; STANDARDS; TELEMEDICINE; TOTAL QUALITY MANAGEMENT;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CONSENSUS; DEFIBRILLATORS, IMPLANTABLE; DISEASE MANAGEMENT; HEART DISEASES; HUMANS; INTERNATIONAL COOPERATION; QUALITY IMPROVEMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMOTE SENSING TECHNOLOGY; TELEMEDICINE;

EID: 84937395717     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.05.008     Document Type: Article

References (92)

1. B.L. Wilkoff, A. Auricchio, J. Brugada, and et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association Heart Rhythm 5 2008 907 925
2. S.M. Al-Khatib, X. Mi, B.L. Wilkoff, L.G. Qualls, C. Frazier-Mills, S. Setoguchi, P.L. Hess, and L.H. Curtis Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice? Circ Arrhythm Electrophysiol 6 2013 108 116
3. F. Halimi, J. Clementy, P. Attuel, X. Dessenne, and W. Amara OEDIPE Trial Investigators. Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial Europace 10 2008 1392 1399
4. S. Dubner, A. Auricchio, J.S. Steinberg, and et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs) Ann Noninvasive Electrocardiol 17 2012 36 56
5. H. Burri Remote follow-up and continuous remote monitoring, distinguished Europace 15 2013 i14 i16
6. N. Varma, B.B. Pavri, B. Stambler, and J. Michalski TRUST Investigators. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems Europace 15 2013 697 703
7. N. Varma, B. Stambler, and S. Chun Detection of atrial fibrillation by implanted devices with wireless data transmission capability Pacing Clin Electrophysiol 28 2005 S133 S136
8. A.K. Jacobs, J.L. Anderson, and J.L. Halperin The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 2014 1373 1384
9. G.H. Crossley, J. Chen, W. Choucair, T.J. Cohen, D.C. Gohn, W.B. Johnson, E.E. Kennedy, L.R. Mongeon, G.A. Serwer, H. Qiao, and B.L. Wilkoff Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers J Am Coll Cardiol 54 2009 2012 2019
10. M.H. Schoenfeld, S.J. Compton, R.H. Mead, D.N. Weiss, L. Sherfesee, J. Englund, and L.R. Mongeon Remote monitoring of implantable cardioverter defibrillators: a prospective analysis Pacing Clin Electrophysiol 27 2004 757 763
11. S.M. Al-Khatib, J.P. Piccini, D. Knight, M. Stewart, N. Clapp-Channing, and G.D. Sanders Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial J Cardiovasc Electrophysiol 21 2010 545 550
12. E.M. Cronin, E.A. Ching, N. Varma, D.O. Martin, B.L. Wilkoff, and B.D. Lindsay Remote monitoring of cardiovascular devices: a time and activity analysis Heart Rhythm 9 2012 1947 1951
13. D.A. Theuns, J.C. Res, and L.J. Jordaens Home monitoring in ICD therapy: future perspectives Europace 5 2003 139 142
14. G.K. Joseph, B.L. Wilkoff, T. Dresing, J. Burkhardt, and Y. Khaykin Remote interrogation and monitoring of implantable cardioverter defibrillators J Interv Card Electrophysiol 11 2004 161 166
15. N. Varma, A.E. Epstein, A. Irimpen, R. Schweikert, and C. Love TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial Circulation 122 2010 325 332
16. N. Varma, J. Michalski, B. Stambler, and B.B. Pavri TRUST Investigators. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations Eur Heart J 35 2014 1345 1352
17. R.P. Ricci, L. Morichelli, A. D'Onofrio, L. Calò, D. Vaccari, G. Zanotto, A. Curnis, G. Buja, N. Rovai, and A. Gargaro Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry Europace 15 2013 970 977
18. R.P. Ricci, L. Morichelli, A. D'Onofrio, L. Calo, D. Vaccari, G. Zanotto, A. Curnis, G. Buja, N. Rovai, and A. Gargaro Manpower and outpatient clinic workload for remote monitoring of patients with cardiac implantable electronic devices: data from the HomeGuide Registry J Cardiovasc Electrophysiol 25 2014 1216 1223
19. G. Hindricks, C. Elsner, C. Piorkowski, M. Taborsky, J.C. Geller, B. Schumacher, J. Bytesnik, and H. Kottkamp Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial Eur Heart J 35 2014 98 105
20. G. Boriani, A. Da Costa, R.P. Ricci, and et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring J Med Internet Res 15 2013 e167
21. G. Crossley, A. Boyle, H. Vitense, Y. Chang, and R.H. Mead The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts J Am Coll Cardiol 57 2011 1181 1189
22. N. Varma Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study Am Heart J 154 2007 1029 1034
23. L. Guedon-Moreau, D. Lacroix, N. Sadoul, J. Clementy, C. Kouakam, J.S. Hermida, E. Aliot, M. Boursier, O. Bizeau, and S. Kacet A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial Eur Heart J 34 2012 605 614
24. A. Lazarus Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database Pacing Clin Electrophysiol 30 2007 S2 S12
25. P. Mabo, F. Victor, P. Bazin, S. Ahres, D. Babuty, A. Da Costa, D. Binet, and J.C. Daubert COMPAS Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial) Eur Heart J 33 2012 1105 1111
26. N. Varma, J. Michalski, A.E. Epstein, and R. Schweikert Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-up (TRUST) Trial Circ Arrhythm Electrophysiol 3 2010 428 436
27. M. Landolina, G.B. Perego, M. Lunati, A. Curnis, G. Guenzati, A. Vicentini, G. Parati, G. Borghi, P. Zanaboni, S. Valsecchi, and M. Marzegalli Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study Circulation 125 2012 2985 2992
28. L. Calò, A. Gargaro, E. De Ruvo, G. Palozzi, L. Sciarra, M. Rebecchi, F. Guarracini, A. Fagagnini, E. Piroli, E. Lioy, and A. Chirico Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits: a single-center prospective and randomized study J Interv Card Electrophysiol 37 2013 69 78
29. G. Hindricks, M. Taborsky, M. Glikson, and et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial Lancet 384 2014 583 590
30. L.A. Saxon, D.L. Hayes, F.R. Gilliam, P.A. Heidenreich, J. Day, M. Seth, T.E. Meyer, P.W. Jones, and J.P. Boehmer Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study Circulation 122 2010 2359 2367
31. Varma NPJ, Snell J, Fischer A, Dalal N, Mittal S. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol. In press. Available at: http://dx.doi.org/10.1016/j.jacc.2015.04.033
32. L. Fauchier, N. Sadoul, C. Kouakam, F. Briand, M. Chauvin, D. Babuty, and J. Clementy Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients Pacing Clin Electrophysiol 28 2005 S255 S259
33. M.J. Raatikainen, P. Uusimaa, M.M. van Ginneken, J.P. Janssen, and M. Linnaluoto Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up Europace 10 2008 1145 1151
34. M. Marzegalli, M. Lunati, M. Landolina, and et al. Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation - ease of use, acceptance, and organizational implications Pacing Clin Electrophysiol 31 2008 1259 1264
35. R.P. Ricci, L. Morichelli, L. Quarta, A. Sassi, A. Porfili, M.T. Laudadio, A. Gargaro, and M. Santini Long-term patient acceptance of and satisfaction with implanted device remote monitoring Europace 12 2010 674 679
36. H.H. Petersen, M.C. Larsen, O.W. Nielsen, F. Kensing, and J.H. Svendsen Patient satisfaction and suggestions for improvement of remote ICD monitoring J Interv Card Electrophysiol 34 2012 317 324
37. L. Morichelli, A. Porfili, L. Quarta, A. Sassi, and R.P. Ricci Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up J Interv Card Electrophysiol 41 2014 203 209
38. L. Guédon-Moreau, D. Lacroix, N. Sadoul, J. Clémenty, C. Kouakam, J.S. Hermida, E. Aliot, and S. Kacet ECOST Investigators. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study Europace 16 2014 1181 1188
39. P. Zanaboni, M. Landolina, M. Marzegalli, M. Lunati, G.B. Perego, G. Guenzati, A. Curnis, S. Valsecchi, F. Borghetti, G. Borghi, and C. Masella Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial J Med Internet 15 2013 e106
40. H. Burri, C. Sticherling, D. Wright, K. Makino, A. Smala, and D. Tilden Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK Europace 15 2013 1601 1608
41. R.P. Ricci, A. Vicentini, A. D'Onofrio, and et al. Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population J Interv Card Electrophysiol 38 2013 101 106
42. C. de Asmundis, D. Ricciardi, M. Namdar, G.-B. Chierchia, A. Sarkozy, and P. Brugada Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome Europace 15 2013 i17 i25
43. P. Neuzil, M. Taborsky, F. Holy, and K. Wallbrueck Early automatic remote detection of combined lead insulation defect and ICD damage Europace 10 2008 556 557
44. N. Varma Remote monitoring for advisories: automatic early detection of silent lead failure Pacing Clin Electrophysiol 32 2009 525 527
45. S. Spencker, N. Coban, L. Koch, A. Schirdewan, and D. Muller Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure Europace 11 2009 483 488
46. L. Guedon-Moreau, C. Kouakam, D. Klug, C. MarquiÉ, F. Brigadeau, S. BoulÉ, H. Blangy, D. Lacroix, J. ClÉMenty, N. Sadoul, and S. Kacet on behalf of the EtI. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial J Cardiovasc Electrophysiol 25 2014 763 770
47. R.P. Ricci, C. Pignalberi, M. Landolina, and et al. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators Heart 100 2014 848 854
48. R.P. Ricci, L. Morichelli, L. Quarta, A. Porfili, B. Magris, L. Giovene, S. Torcinaro, and A. Gargaro Effect of daily remote monitoring on pacemaker longevity: a retrospective analysis Heart Rhythm 12 2015 330 337
49. Medtronic. Clinician Manual Supplement ProtectaTM XT/ProtectaTM Projected service life information related to remote monitoring. EVERA™ XT VR DVBB1D1. Manual No: M945739A001A.
50. N. Varma, and M.A. Johnson Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter-defibrillators assessed by remote monitoring Pacing Clin Electrophysiol 32 2009 S42 S46
51. R.P. Ricci, L. Morichelli, and M. Santini Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation Europace 11 2009 54 61
52. R.P. Ricci, L. Morichelli, A. D'Onofrio, L. Calo, D. Vaccari, G. Zanotto, A. Curnis, G. Buja, N. Rovai, and A. Gargaro Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry Europace 15 2013 970 977
53. M.V. Orlov, J.K. Ghali, M. Araghi-Niknam, L. Sherfesee, D. Sahr, and D.A. Hettrick Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial Pacing Clin Electrophysiol 30 2007 404 411
54. J.W. Cheung, R.J. Keating, K.M. Stein, S.M. Markowitz, S. Iwai, B.K. Shah, B.B. Lerman, and S. Mittal Newly detected atrial fibrillation following dual chamber pacemaker implantation J Cardiovasc Electrophysiol 17 2006 1323 1328
55. T.J. Bunch, J.D. Day, B. Olshansky, K.Q. Stolen, and C.M. Mullin INTRINSIC RV Study Investigators. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality Heart Rhythm 6 2009 2 8
56. G.L. Botto, L. Padeletti, M. Santini, and et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events J Cardiovasc Electrophysiol 20 2009 241 248
57. T.V. Glotzer, A.S. Hellkamp, J. Zimmerman, and et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST) Circulation 107 2003 1614 1619
58. A. Capucci, M. Santini, L. Padeletti, and et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers J Am Coll Cardiol 46 2005 1913 1920
59. T.V. Glotzer, E.G. Daoud, D.G. Wyse, D.E. Singer, M.D. Ezekowitz, C. Hilker, C. Miller, D. Qi, and P.D. Ziegler The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
60. N. Shanmugam, A. Boerdlein, J. Proff, P. Ong, O. Valencia, S.K. Maier, W.R. Bauer, V. Paul, and S. Sack Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population Europace 14 2012 230 237
61. J.S. Healey, S.J. Connolly, M.R. Gold, and et al. Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
62. M. Brambatti, S.J. Connolly, M.R. Gold, and et al. Temporal relationship between subclinical atrial fibrillation and embolic events Circulation 129 2014 2094 2099
63. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GYH, Ip J, Holcomb R, Akar JG, Halperin JL, on behalf of the IMPACT Investigators. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. In press. Available at: http://eurheartj.oxfordjournals.org/content/ehj/early/2015/04/22/eurheartj.ehv115.full.pdf
64. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 2246 2280
65. D. Vollmann, H. Nägele, P. Schauerte, U. Wiegand, C. Butter, G. Zanotto, A. Quesada, A. Guthmann, M.R. Hill, and B. Lamp EISOS Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure Eur Heart J 28 2007 1835 1840
66. V.M. Conraads, L. Tavazzi, M. Santini, F. Oliva, B. Gerritse, C.M. Yu, and M.R. Cowie Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial Eur Heart J 32 2011 2266 2273
67. G.B. Perego, M. Landolina, G. Vergara, and et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization J Interv Card Electrophysiol 23 2008 235 242
68. R.S. Small, W. Wickemeyer, R. Germany, B. Hoppe, J. Andrulli, P.A. Brady, M. Labeau, J. Koehler, S. Sarkar, D.A. Hettrick, and W.H. Tang Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert J Card Fail 15 2009 475 481
69. D.J. Whellan, K.T. Ousdigian, S.M. Al-Khatib, W. Pu, S. Sarkar, C.B. Porter, B.B. Pavri, and C.M. O'Connor Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study J Am Coll Cardiol 55 2010 1803 1810
70. D. Catanzariti, M. Lunati, M. Landolina, and et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure Pacing Clin Electrophysiol 32 2009 363 370
71. M. Maines, D. Catanzariti, C. Cemin, C. Vaccarini, and G. Vergara Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study J Interv Card Electrophysiol 19 2007 201 207
72. D.J. van Veldhuisen, F. Braunschweig, V. Conraads, and et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure Circulation 124 2011 1719 1726
73. G. Hindricks, M. Taborsky, M. Glikson, and et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial Lancet 384 2014 583 590
74. W.T. Abraham, P.B. Adamson, R.C. Bourge, and et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
75. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, and et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 61 2013 e6 e75
76. I. Gussak, P. Brugada, J. Brugada, C. Antzelevitch, M. Osbakken, and P. Bjerregaard ECG phenomenon of idiopathic and paradoxical short QT intervals Card Electrophysiol Rev 6 2002 49 53
77. C. Antzelevitch, P. Brugada, M. Borggrefe, and et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association Circulation 111 2005 659 670
78. C. de Asmundis, D. Ricciardi, M. Namdar, G.B. Chierchia, A. Sarkozy, and P. Brugada Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome Europace 15 2013 i17 i25
79. P.J. Schwartz, C. Spazzolini, S.G. Priori, and et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry Circulation 122 2010 1272 1282
80. C.I. Berul, G.F. Van Hare, N.J. Kertesz, A.M. Dubin, F. Cecchin, K.K. Collins, B.C. Cannon, M.E. Alexander, J.K. Triedman, E.P. Walsh, and R.A. Friedman Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients J Am Coll Cardiol 51 2008 1685 1691
81. B.J. Maron, P. Spirito, W.K. Shen, and et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
82. F. Sacher, V. Probst, M. Bessouet, and et al. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population Europace 11 2009 489 494
83. D.L. Hayes, J.P. Boehmer, J.D. Day, F.R. Gilliam III, P.A. Heidenreich, M. Seth, P.W. Jones, and L.A. Saxon Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival Heart Rhythm 8 2011 1469 1475
84. F.R. Gilliam, D.L. Hayes, J.P. Boehmer, J. Day, P.A. Heidenreich, M. Seth, P.W. Jones, K.M. Stein, and L.A. Saxon Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study J Cardiovasc Electrophysiol 22 2011 1023 1029
85. Heart Rhythm Society. Resource - Specifications for HRS-developed Measures. 2015.A HRS-developed physician-level performance measure "In-Person Evaluation Following Implantation of a Cardiovascular Implantable Electronic Device (CIED)" is available as a tool to measure adherence to in-person follow-up. www.hrsonline.org/hrs/Practice-Guidance/Quality-Outcomes-Reporting/Physician-Quality-Reporting-Systems-PQRS/Resource-Specifications-for-HRS-Measures. Accessed April 8, 2015.
86. S.L. Winters, F.M. Kusumoto, J.M. Miller, and D.J. Slotwiner The role of the Heart Rhythm Society in integrating the healthcare enterprise Heart Rhythm 4 2007 122 124
87. IEEE. 11073-10103-2012 - Health informatics - Point-of-care medical device communication Part 10103: Nomenclature - Implantable device, cardiac. http://standards.ieee.org/findstds/standard/11073-10103-2012.html. Accessed April 8, 2015.
88. Integrating the Healthcare Enterprise. Patient Care Device Technical Framework. 2014. http://www.ihe.net/Technical-Frameworks/#pcd. Accessed April 8, 2015.
89. H. Heidbuchel, G. Hindricks, P. Broadhurst, and et al. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring Eur Heart J 36 2015 158 169
90. Amy Dockser Marcus CW. Heart gadgets test privacy - law limits. Wall St J. Available at: http://www.wsj.com/articles/SB10001424052970203937004578078820874744076
91. D. Halperin, T.S. Heydt-Benjamin, B. Ransford, S.S. Clark, B. Defen, W. Morgan, K. Fu, T. Kohno, and W.H. Maisel Pacemakers and implantable cardiac defibrillators: software radio attacks and zero-power defenses. security and privacy Proceedings of the IEEE Symposium on Security and Privacy 2008 129 142
92. T. Sanna, H-C Diener, R.S. Passman, V. Di Lazzaro, R.A. Bernstein, C.A. Morillo, and et al. Cryptogenic stroke and underlying atrial fibrillation New England Journal of Medicine 370 26 2014 2478 2486